康臣药业(01681)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01681 康臣药业

未开盘 08-14 16:08:36

13.650

-0.140

-1.02%

最高13.860	最低13.520	成交量117.77万
今开13.860	昨收13.790	日振幅2.47%
总市值114.52亿	流通市值114.52亿	总股本8.39亿
成交额1,602万	换手率0.14%	流通股本8.39亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01681","market":"HK","secType":"STK","nameCN":"康臣药业","latestPrice":13.65,"timestamp":1786694916003,"preClose":13.79,"halted":0,"volume":1177671,"delay":0,"changeRate":-0.010152284263959303,"floatShares":839000000,"shares":839000000,"eps":1.4661473030022443,"marketStatus":"未开盘","change":-0.14,"latestTime":"08-14 16:08:36","open":13.86,"high":13.86,"low":13.52,"amount":16018783,"amplitude":0.024656,"askPrice":13.65,"askSize":2000,"bidPrice":13.62,"bidSize":2000,"shortable":3,"etf":0,"ttmEps":1.4661473030022443,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1786930200000},"marketStatusCode":0,"adr":0,"listingDate":1387382400000,"exchange":"SEHK","adjPreClose":13.79,"dividendRate":0.055584,"openAndCloseTimeList":[[1786671000000,1786680000000],[1786683600000,1786694400000]],"volumeRatio":0.8481080753357927,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01681/","defaultTab":"news","newsList":[{"id":"2658298157","title":"康臣药业(01681.HK)拟8月26日举行董事会会议以审批中期业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2658298157","media":"中金财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658298157?lang=zh_cn&edition=full","pubTime":"2026-08-10 16:47","pubTimestamp":1786351622,"startTime":"0","endTime":"0","summary":"格隆汇8月10日丨康臣药业(01681.HK)宣布，公司将于2026年8月26日(星期三)举行董事局会议，以处理以下事项：1.审阅及批准公司及其附属公司截至2026年6月30日止六个月未经审核综合中期业绩；2.审阅及批准将根据香港联合交易所有限公司证券上市规则公布的中期业绩公告；3.考虑派发中期股息(如有)；及4.考虑及批准其他事项(如有)。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260810/32330468.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1191","BK1606","01681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154908264","title":"康臣药业更新2026年7月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1154908264","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1154908264?lang=zh_cn&edition=full","pubTime":"2026-08-04 17:46","pubTimestamp":1785836814,"startTime":"0","endTime":"0","summary":"康臣药业集团有限公司于2026年8月4日发布截至2026年7月31日的月度证券变动报告。公告显示，公司的法定股本及注册股本继续维持在5,000,000,000股，合计约5亿港元，与上月保持一致。截至2026年7月底，康臣药业已发行股份数量为839,049,111股，库存股份数量为2,498,000股，总发行股本数为841,547,111股，亦与上月持平。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651118884","title":"康臣药业首度入围中国医药工业百强 并获评“投资价值潜力企业”","url":"https://stock-news.laohu8.com/highlight/detail?id=2651118884","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651118884?lang=zh_cn&edition=full","pubTime":"2026-07-13 17:58","pubTimestamp":1783936709,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK1606","BK1191","01681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648652216","title":"光大证券：首予康臣药业(01681.HK)“买入”评级 目标价17.73港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2648652216","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648652216?lang=zh_cn&edition=full","pubTime":"2026-07-03 16:33","pubTimestamp":1783067636,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1606","BK1191","01681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648655766","title":"【券商聚焦】光大证券首予康臣药业(01681)“买入”评级 指尿毒清颗粒增长空间广阔","url":"https://stock-news.laohu8.com/highlight/detail?id=2648655766","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648655766?lang=zh_cn&edition=full","pubTime":"2026-07-03 14:09","pubTimestamp":1783058947,"startTime":"0","endTime":"0","summary":"金吾财讯 | 光大证券发布研报指，康臣药业 是肾科中成药龙头企业，深耕肾科三十载，搭建了“1+6”产品矩阵。研报核心逻辑聚焦于公司旗舰产品尿毒清颗粒的广阔成长空间。作为独家品种，尿毒清颗粒循证医学证据充分，2025年实现营收22.79亿元，同比增长21%，稳居肾病中成药品类市场占有率第一。光大证券测算，尿毒清颗粒市场规模空间有望达到78-139亿元人民币，长期增长潜力充足。首次覆盖，给予“买入”评级。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250109/MWQ0NzJkZTcxMzM4ODY4MjA2MzM0OTUz.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MWQ0NzJkZTcxMzM4ODY4MjA2MzM0OTUz.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1985080","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["601788","01681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191796556","title":"康臣药业发布2026年6月股份变动月报：当月回购2,039,000股","url":"https://stock-news.laohu8.com/highlight/detail?id=1191796556","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1191796556?lang=zh_cn&edition=full","pubTime":"2026-07-02 20:12","pubTimestamp":1782994344,"startTime":"0","endTime":"0","summary":"康臣药业集团有限公司于2026年7月2日公布2026年6月股份变动月报，报告期为截至2026年6月30日。公告显示，公司法定股本即注册股本维持不变，仍为5,000,000,000股普通股，注册股本总额500,000,000港元。已发行股份总数与上月底保持一致，均为841,547,111股，其中已发行股份于期末为839,049,111股，库存股份为2,498,000股。根据月报，康臣药业于2026年6月内通过一系列股份购回将2,039,000股转为库存股份，期间无新增发行、行使股份期权或注销股份。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135881530","title":"康臣药业集团有限公司：6月30日回购63,000股，涉资约79.16万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1135881530","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1135881530?lang=zh_cn&edition=full","pubTime":"2026-06-30 20:22","pubTimestamp":1782822151,"startTime":"0","endTime":"0","summary":"康臣药业集团有限公司（股票代码：01681）6月30日发布翌日披露报表。公告显示，公司当日在香港联交所场内回购普通股63,000股，约占回购前已发行股本的0.0075%，每股回购价介乎12.50港元至12.58港元，总耗资约79.16万港元。\n本次回购后，公司已发行股本变动为839,049,111股，库藏股数量增至2,498,000股。此前回购授权于2026年5月26日获股东大会通过，授权总数为84,120,311股，公司迄今已回购2,154,000股，占该授权总数约2.5606%。\n公司确认已遵守香港联合交易所有限公司证券上市规则及相关法律法规。公告由公司秘书高海恩签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康臣药业集团有限公司：6月30日回购63,000股，涉资约79.16万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647655593","title":"康臣药业(01681)6月30日斥资79.2万港元回购6.3万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2647655593","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647655593?lang=zh_cn&edition=full","pubTime":"2026-06-30 20:20","pubTimestamp":1782822058,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康臣药业(01681)发布公告，于2026年6月30日斥资79.2万港元回购6.3万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1461436.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK1606","01681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198761375","title":"康臣药业6月26日回购15.6万股股份，耗资约195.81万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1198761375","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1198761375?lang=zh_cn&edition=full","pubTime":"2026-06-26 18:06","pubTimestamp":1782468400,"startTime":"0","endTime":"0","summary":"康臣药业于2026年6月26日公告显示，当日公司在香港联交所场内回购普通股15.6万股，占回购前已发行股份约0.0186%。回购价格区间介乎每股12.48港元至12.62港元，合计支付约195.81万港元。完成后，公司已发行股份由8.39268111亿股减少至8.39112111亿股，库存股份数量增至243.5万股，合计已发行股本仍为8.41547111亿股。公告同时披露，此次股票回购依据2026年5月26日通过的回购授权进行，该授权可回购股票总数为8412.0311万股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康臣药业6月26日回购15.6万股股份，耗资约195.81万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646568703","title":"康臣药业(01681)6月26日耗资195.81万港元回购15.6万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2646568703","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2646568703?lang=zh_cn&edition=full","pubTime":"2026-06-26 18:03","pubTimestamp":1782468200,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康臣药业(01681)公布，2026年6月26日耗资195.81万港元回购15.6万股股份。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1459488.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01681","BK1191","BK1606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108950236","title":"康臣药业：2026年6月25日回购9万股，耗资约115.50万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1108950236","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1108950236?lang=zh_cn&edition=full","pubTime":"2026-06-25 20:15","pubTimestamp":1782389754,"startTime":"0","endTime":"0","summary":"","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康臣药业：2026年6月25日回购9万股，耗资约115.50万港元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107974446","title":"康臣药业6月24日回购3万股股份，涉资约37.89万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1107974446","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1107974446?lang=zh_cn&edition=full","pubTime":"2026-06-24 20:32","pubTimestamp":1782304320,"startTime":"0","endTime":"0","summary":"康臣药业于2026年6月24日发布公告，公司当日于香港联交所场内回购普通股合计3万股，占该次回购前公司已发行股本约0.0036%。每股回购价为12.63港元，合计涉资约37.89万港元。根据公告，康臣药业于2026年5月26日获得股东大会批准的股份购回授权，授权总额为84,120,311股。公告同时披露，自2026年6月24日开始的30天内，未经香港联交所批准，康臣药业将不会发行任何新股或出售、转让任何库藏股份，亦不会公布此类计划。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康臣药业6月24日回购3万股股份，涉资约37.89万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645818199","title":"康臣药业(01681)6月24日斥资37.89万港元回购3万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2645818199","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645818199?lang=zh_cn&edition=full","pubTime":"2026-06-24 20:27","pubTimestamp":1782304044,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康臣药业(01681)发布公告，于2026年6月24日斥资37.89万港元回购3万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1458302.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01681","BK1606","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645247140","title":"康臣药业(01681)6月22日斥资509.21万港元回购39.8万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2645247140","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645247140?lang=zh_cn&edition=full","pubTime":"2026-06-22 20:12","pubTimestamp":1782130340,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康臣药业(01681)发布公告，该公司于2026年6月22日斥资509.21万港元回购39.8万股股份，每股回购价格为12.67-12.88港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1457124.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","01681","BK1606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177648492","title":"康臣药业：6月22日回购39.8万股股份，总额约509.21万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1177648492","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1177648492?lang=zh_cn&edition=full","pubTime":"2026-06-22 20:08","pubTimestamp":1782130087,"startTime":"0","endTime":"0","summary":"康臣药业集团有限公司（股票代码：01681）于2026年6月22日公告，公司当日于香港联交所场内回购普通股39.8万股，占已发行股本约0.0474%。每股回购价介乎12.67港元至12.88港元，合计涉资约509.21万港元。\n本次股份购回完成后，公司已发行股本增至839,388,111股，库存股为2,159,000股，总股份数为841,547,111股。本次回购依据2026年5月26日通过的购回授权，公司可回购股份总数为84,120,311股，截至目前已累计回购1,815,000股。\n公司确认，此次回购已遵守相关上市规则及法律规定。公告由公司秘书高海恩签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康臣药业：6月22日回购39.8万股股份，总额约509.21万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644085553","title":"康臣药业(01681)6月18日斥资77.01万港元回购5.8万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2644085553","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2644085553?lang=zh_cn&edition=full","pubTime":"2026-06-18 20:37","pubTimestamp":1781786258,"startTime":"0","endTime":"0","summary":"康臣药业(01681)发布公告，于2026年6月18日斥资77.01万港元回购5.8万股。","market":"us","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_37.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_37.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1456413.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1606","BK1191","01681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143637898","title":"康臣药业回购5.8万股股份，耗资约77.01万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1143637898","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1143637898?lang=zh_cn&edition=full","pubTime":"2026-06-18 20:36","pubTimestamp":1781786161,"startTime":"0","endTime":"0","summary":"康臣药业集团有限公司于2026年6月18日披露公告称，公司当日在香港联合交易所场内回购普通股5.8万股，占回购前已发行股本约0.0069%，回购价格介乎每股13.19港元至13.35港元，合计耗资约77.01万港元。此次回购的股份将被列作库藏股，库藏股总数由1,703,000股增至1,761,000股。本次回购完成后，公司已发行股份总数由回购前的839,844,111股减少至839,786,111股，而公司股份总数仍为841,547,111股。该回购依据公司于2026年5月26日通过的股份回购授权展开，剩余可购回股份数为84,120,311股。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康臣药业回购5.8万股股份，耗资约77.01万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644274537","title":"康臣药业(01681)6月17日斥资222.07万港元回购16.8万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2644274537","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2644274537?lang=zh_cn&edition=full","pubTime":"2026-06-17 19:57","pubTimestamp":1781697442,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康臣药业(01681)发布公告，于2026年6月17日斥资222.07万港元回购16.8万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1455738.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1606","BK1191","01681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194425362","title":"康臣药业6月17日回购16.80万股，耗资约222.07万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1194425362","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1194425362?lang=zh_cn&edition=full","pubTime":"2026-06-17 19:56","pubTimestamp":1781697380,"startTime":"0","endTime":"0","summary":"康臣药业集团有限公司于2026年6月17日发布公告称，公司当日在香港联交所场内回购股份16.80万股，约占本次回购前已发行股本的0.02%。每股回购价格介乎13.20港元至13.24港元，总计涉资约222.07万港元。此次回购完成后，公司已发行股本变动为839,844,111股，库存股份增至1,703,000股，公司总已发行股本保持在841,547,111股。截至本次回购前，公司自获得授权起已于包括香港联交所在内的证券交易所累计回购1,359,000股，占购回授权通过当日已发行股份总数的1.6155%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康臣药业6月17日回购16.80万股，耗资约222.07万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117315501","title":"康臣药业集团：6月16日回购11.10万股股份，耗资约149.78万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1117315501","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1117315501?lang=zh_cn&edition=full","pubTime":"2026-06-16 20:06","pubTimestamp":1781611616,"startTime":"0","endTime":"0","summary":"康臣药业集团有限公司于2026年6月16日发布公告称，公司于当日在香港联交所回购普通股111,000股，占截至回购日前已发行股本约0.0132%。回购价格介乎每股13.44港元至13.56港元，合计耗资1,497,750港元，折合约149.78万港元。据公告披露，康臣药业集团已于2026年5月26日通过回购授权，可回购最多84,120,311股，截至目前已累计回购1,191,000股，占授权规模约1.4158%。公司表示，本次回购遵守香港联交所证券上市规则及相关法律法规规定。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康臣药业集团：6月16日回购11.10万股股份，耗资约149.78万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01681"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.chinaconsun.com","stockEarnings":[{"period":"1week","weight":-0.025},{"period":"1month","weight":-0.0257},{"period":"3month","weight":-0.0634},{"period":"6month","weight":-0.2239},{"period":"1year","weight":0.0876},{"period":"ytd","weight":-0.1023}],"compareEarnings":[{"period":"1week","weight":-0.0215},{"period":"1month","weight":0.0177},{"period":"3month","weight":-0.0326},{"period":"6month","weight":-0.0546},{"period":"1year","weight":-0.0158},{"period":"ytd","weight":-0.02}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"康臣药业集团有限公司是一家主要从事药品生产及销售业务的公司。该公司通过两个部门开展业务。康臣药业分部主要从事生产及销售现代中成药及医用成像对比剂业务。玉林制药分部主要从事生产及销售传统中成药业务。该公司的产品主要包括肾科药物、妇儿药物、对比剂、骨科药物、皮肤科药物、肝胆药物和其他。该公司主要在中国国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.615385,"avgChangeRate":0.045449},{"month":2,"riseRate":0.538462,"avgChangeRate":0.016847},{"month":3,"riseRate":0.461538,"avgChangeRate":0.017193},{"month":4,"riseRate":0.692308,"avgChangeRate":0.059405},{"month":5,"riseRate":0.538462,"avgChangeRate":0.023099},{"month":6,"riseRate":0.384615,"avgChangeRate":-0.004058},{"month":7,"riseRate":0.538462,"avgChangeRate":-0.002909},{"month":8,"riseRate":0.538462,"avgChangeRate":0.011535},{"month":9,"riseRate":0.583333,"avgChangeRate":0.028359},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.025966},{"month":11,"riseRate":0.5,"avgChangeRate":0.008692},{"month":12,"riseRate":0.583333,"avgChangeRate":0.021375}],"exchange":"SEHK","name":"康臣药业","nameEN":"CONSUN PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康臣药业(01681)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康臣药业(01681)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康臣药业,01681,康臣药业股票,康臣药业股票老虎,康臣药业股票老虎国际,康臣药业行情,康臣药业股票行情,康臣药业股价,康臣药业股市,康臣药业股票价格,康臣药业股票交易,康臣药业股票购买,康臣药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康臣药业(01681)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康臣药业(01681)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}